Kefeng Lei
Impact in
-
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
-
- Heat shock proteins research
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- ATP Synthase and ATPases Research
Papers in
-
- Circular RNAs in diseases 2
- RNA Research and Splicing 2
- RNA modifications and cancer 2
- Oncology 5
- Peptidase Inhibition and Analysis 2
- Co-authors
- Jiahui Wang (2 shared papers)Qiuran Xu (2 shared papers)Liu Yang (2 shared papers)Lijie Li (1 shared paper)Changwei Dou (1 shared paper)Hang-xing Bao (1 shared paper)Jun Zhang (1 shared paper)Kangsheng Tu (1 shared paper)
- Journals
- Cancer Letters (2 papers)Advances in Therapy (2 papers)PeerJ (1 paper)PLoS ONE (1 paper)Journal of Zhejiang University SCIENCE B (1 paper)
- Partner nations
- ChinaUnited StatesBangladesh
In The Last Decade
Kefeng Lei
18 papers receiving 369 citations
Peers
Comparison fields: 5 of 68
- Cancer Research 117
- Molecular Biology 205
- Oncology 50
- Cell Biology 32
- Biochemistry 9
Countries citing papers authored by Kefeng Lei
This map shows the geographic impact of Kefeng Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kefeng Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kefeng Lei more than expected).
Fields of papers citing papers by Kefeng Lei
This network shows the impact of papers produced by Kefeng Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kefeng Lei. The network helps show where Kefeng Lei may publish in the future.
Co-authors
The 25 scholars most cited alongside Kefeng Lei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 194 | |
| 2 | 2007 | 45 | |
| 3 | 2018 | 24 | |
| 4 | 2016 | 15 | |
| 5 | 2021 | 14 | |
| 6 | 2011 | 13 | |
| 7 | 2020 | 12 | |
| 8 | 2019 | 10 | |
| 9 | 2012 | 9 | |
| 10 | 2022 | 8 | |
| 11 | 2019 | 6 | |
| 12 | 2022 | 5 | |
| 13 | 2018 | 5 | |
| 14 | 2020 | 4 | |
| 15 | 2025 | 3 | |
| 16 | [Knocking down osteopontin expression by specific siRNA reduces the in vitro invasiveness of human hepatocellular carcinoma cells]. | 2006 | 2 |
| 17 | 2024 | 2 | |
| 18 | [Interaction of SerpinB5 and MAFbx in gastric cancer cell and its action site]. | 2012 | 1 |
| 19 | 2024 | 0 | |
| 20 | 2026 | 0 |
About Kefeng Lei
Kefeng Lei is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Surgery and Epidemiology, having authored 21 papers that have together received 372 indexed citations. Recurring topics across this work include Circular RNAs in diseases (2 papers), Thyroid Cancer Diagnosis and Treatment (2 papers), RNA Research and Splicing (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Multiple and Secondary Primary Cancers (2 papers), Peptidase Inhibition and Analysis (2 papers), Gastric Cancer Management and Outcomes (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Cancer Research (117 citations), Molecular Biology (205 citations), Oncology (50 citations), Cell Biology (32 citations) and Biochemistry (9 citations). Kefeng Lei has collaborated with scholars based in China, United States and Bangladesh. Frequent co-authors include Jiahui Wang, Qiuran Xu, Liu Yang, Lijie Li, Changwei Dou, Hang-xing Bao, Jun Zhang, Kangsheng Tu, Jian‐Feng Tu and Yufeng Wang. Their work appears in journals such as Cancer Letters, Advances in Therapy, PeerJ, PLoS ONE and Journal of Zhejiang University SCIENCE B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.